These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26250130)

  • 21. Chemoradiotherapy of esophageal carcinoma.
    Poplin EA; Khanuja PS; Kraut MJ; Herskovic AM; Lattin PB; Cummings G; Gaspar LE; Kinzie JL; Steiger Z; Vaitkevicius VK
    Cancer; 1994 Aug; 74(4):1217-24. PubMed ID: 8055441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Phase II Study of Concurrent Chemoradiotherapy With Paclitaxel and Cisplatin for Inoperable Esophageal Squamous Cell Carcinoma.
    Tang HR; Ma HF; An SM; Badakhshi H; Deng JY; Zhang JH; Chen Y; Zhang Z; Guo XM; Jiang GL; Zhao KL
    Am J Clin Oncol; 2016 Aug; 39(4):350-4. PubMed ID: 24732811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of residual metastatic lymph node lesion following definitive chemoradiotherapy for T4 esophageal cancer, successfully treated by outpatient clinic-based sequential chemotherapy with docetaxel followed by S-1].
    Yoneda M; Fujiwara H; Shiozaki A; Komatsu S; Ichikawa D; Okamoto K; Murayama Y; Kuriu Y; Ikoma H; Nakanishi M; Ochiai T; Kokuba Y; Otsuji E
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2397-400. PubMed ID: 22202394
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Unresectable stage 4-cancer of the esophagus well responded to combined chemoradiotherapy--a case report].
    Hirao E; Saito T; Kuwahara A; Shigemitsu Y; Kinoshita T; Shimoda K; Miyahara M; Kobayashi M
    Nihon Gan Chiryo Gakkai Shi; 1990 Jul; 25(7):1497-501. PubMed ID: 1698902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concurrent erlotinib and radiotherapy for chemoradiotherapy-intolerant esophageal squamous cell carcinoma patients: results of a pilot study.
    Zhai Y; Hui Z; Wang J; Zou S; Liang J; Wang X; Lv J; Chen B; Zhu H; Wang L
    Dis Esophagus; 2013 Jul; 26(5):503-9. PubMed ID: 22862289
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II study of concurrent chemoradiotherapy at the dose of 50.4 Gy with elective nodal irradiation for Stage II-III esophageal carcinoma.
    Kato K; Nakajima TE; Ito Y; Katada C; Ishiyama H; Tokunaga SY; Tanaka M; Hironaka S; Hashimoto T; Ura T; Kodaira T; Yoshimura K
    Jpn J Clin Oncol; 2013 Jun; 43(6):608-15. PubMed ID: 23585687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Basaloid squamous cell carcinoma of the esophagus: report of two cases.
    Akagi I; Miyashita M; Makino H; Nomura T; Ohkawa K; Tajiri T
    J Nippon Med Sch; 2008 Dec; 75(6):354-60. PubMed ID: 19155575
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive radiotherapy in locally advanced esophageal cancer with atelectasis: a case report.
    Sakanaka K; Fujii K; Mizowaki T
    BMC Cancer; 2020 Jan; 20(1):21. PubMed ID: 31906910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Therapeutic and histological features of basaloid squamous cell carcinoma].
    Helling K; Loddenkemper C; Scherer H
    HNO; 2003 Dec; 51(12):993-7. PubMed ID: 14647929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Basaloid-squamous cell carcinoma of the esophagus: diagnosis based on immunohistochemical analysis.
    Nishimura W; Naomoto Y; Hamaya K; Toda S; Miyagi K; Tanaka N
    J Gastroenterol Hepatol; 2001 May; 16(5):586-90. PubMed ID: 11350561
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of endocrine cell carcinoma of the esophagus successfully treated by chemoradiotherapy].
    Murase T; Higurashi T; Akatsuka S; Nagase H; Kawana K; Otani S; Tani R; Kojima T; Uchiyama S; Eduka A; Iinuma M; Fujita Y; Watai K
    Gan To Kagaku Ryoho; 2012 Jan; 39(1):111-3. PubMed ID: 22241363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A multi-centered randomized controlled study of neo-adjuvant chemoradiotherapy followed by surgery versus surgery alone for locally advanced squamous cell carcinoma of esophagus: an interim analysis].
    YANG H; FU JH; LIU MZ; FANG WT; WANG JM; CHEN YP; CHEN ZJ; XIANG JQ; YANG HJ; MAO WM; ZHENG X; ZHU CC; KONG M; HAN YT; LI T
    Zhonghua Yi Xue Za Zhi; 2012 Apr; 92(15):1028-32. PubMed ID: 22781642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definite intensity-modulated radiotherapy with concurrent chemotherapy more than 4 cycles improved survival for patients with locally-advanced or inoperable esophageal squamous cell carcinoma.
    Hsieh HY; Hsu CP; Yeh HL; Chuang CY; Lin JF; Chang CF
    Kaohsiung J Med Sci; 2018 May; 34(5):281-289. PubMed ID: 29699635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II feasibility study of preoperative concurrent chemoradiotherapy with cisplatin plus 5-fluorouracil and elective lymph node irradiation for clinical stage II/III esophageal squamous cell carcinoma.
    Hashimoto J; Kato K; Ito Y; Kojima T; Akimoto T; Daiko H; Hamamoto Y; Matsushita H; Katano S; Hara H; Tanaka Y; Saito Y; Nagashima K; Igaki H
    Int J Clin Oncol; 2019 Jan; 24(1):60-67. PubMed ID: 30109544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the esophagus or gastroesophageal junction: long-term results of a randomized clinical trial.
    von Döbeln GA; Klevebro F; Jacobsen AB; Johannessen HO; Nielsen NH; Johnsen G; Hatlevoll I; Glenjen NI; Friesland S; Lundell L; Yu J; Nilsson M
    Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30137281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of multiple advanced esophageal carcinomas with abdominal LN metastases showing complete response after chemoradiotherapy with concurrent cisplatin, 5-FU and adriamycin chemotherapy].
    Yasuda T; Yano M; Takiguchi S; Kimura Y; Fujiwara Y; Monden M
    Gan To Kagaku Ryoho; 2003 Oct; 30(11):1737-40. PubMed ID: 14619507
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complete Response in Far-Advanced Esophageal Cancer Treated with Induction Chemotherapy Followed by Definitive Chemoradiotherapy].
    Kaburagi T; Harada H; Koizumi W; Aga K; Watanabe H; Seki H; Yasui N; Sakata M; Matsumoto H; Shimada A
    Gan To Kagaku Ryoho; 2015 Sep; 42(9):1103-6. PubMed ID: 26469169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Concurrent cetuximab and radiotherapy after docetaxel-cisplatin induction chemotherapy in stage III NSCLC: satellite--a phase II study from the Swedish Lung Cancer Study Group.
    Hallqvist A; Wagenius G; Rylander H; Brodin O; Holmberg E; Lödén B; Ewers SB; Bergström S; Wichardt-Johansson G; Nilsson K; Ekberg L; Sederholm C; Nyman J
    Lung Cancer; 2011 Feb; 71(2):166-72. PubMed ID: 20541833
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-dose definitive concomitant chemoradiotherapy in non-metastatic locally advanced esophageal cancer: toxicity and outcome.
    Hurmuzlu M; Monge OR; Smaaland R; Viste A
    Dis Esophagus; 2010 Apr; 23(3):244-52. PubMed ID: 19664075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Salvage Surgery after CRT for Advanced Esophageal Cancer Resulting in a Pathological Complete Response and More Than Five Years' Survival].
    Kaida S; Murata S; Yamaguchi T; Ohtake R; Takebayashi K; Yamamoto H; Ueki T; Miyake T; Iida H; Akabori H; Sonoda H; Mori T; Shimizu T; Naka S; Tani M
    Gan To Kagaku Ryoho; 2016 Nov; 43(12):2007-2009. PubMed ID: 28133204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.